Sacklers to pay up to $7bn in Purdue Pharma's opioid settlement plan [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
The latest scheme will see the company's owners, the Sackler family, contribute around $6.5bn in instalments over the next 15 years, with $1.5bn to be paid on the day the plan becomes active. An additional $500m could be provided by the Sacklers if international pharmaceutical businesses they sell reach a higher-than-expected value. Purdue is expected to raise and contribute $900m while dissolving and transforming into a new public benefit company. The non-profit company that emerges will develop and distribute opioid use disorder and overdose rescue medicines. The Sacklers will have no links to the new company. The bankruptcy plan is devised to ensure that victims of the opioid crisis receive appropriate compensation and that local gover
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry PharmaPR Newswire
- Lumicera Secures Purchase Agreement for Stelara® Biosimilar, Delivering Major Cost Savings [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target lowered by analysts at Bank of America Co. from $23.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
TEVA
Earnings
- 1/29/25 - Beat
TEVA
Sec Filings
- 3/7/25 - Form 4
- 3/7/25 - Form 4
- 3/7/25 - Form 4
- TEVA's page on the SEC website